Relationships of methacholine and AMP responsiveness with peak expiratory flow variability in children with asthma

Clinical and Experimental Allergy

Volumn 37, Issue 8, 2007, Pages 1158-1164

  Yoo, Y ^b   Kim, D K ^a   Yu, J ^a   Choi, S H ^a   Kim, C K ^c   Koh, Y Y ^a  

^a Seoul National University Hospital   (South Korea)

^b College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

Adenosine 5 monophosphate; Asthma; Bronchial responsiveness; Methacholine; Peak expiratory flow variability

Indexed keywords

ADENOSINE PHOSPHATE; METHACHOLINE;

ADOLESCENT; ARTICLE; ASTHMA; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROVOCATION TEST; SCHOOL CHILD;

ADENOSINE MONOPHOSPHATE; ADOLESCENT; ASTHMA; BRONCHIAL PROVOCATION TESTS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHACHOLINE CHLORIDE; MUSCARINIC AGONISTS; PEAK EXPIRATORY FLOW RATE; REPRODUCIBILITY OF RESULTS;

EID: 34447536425     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02766.x     Document Type: Article

References (33)

1. Smith L, McFadden ER Jr. Bronchial hyperreactivity revisited. Ann Allergy Asthma Immunol 1995 74 : 454 70.
2. de Meer G, Marks GB, Postma DS. Direct or indirect stimuli for bronchial challenge testing: what is the relevance for asthma epidemiology? Clin Exp Allergy 2004 34 : 9 16.
3. Quanjer PH, Lebowitz MD, Gregg I, Miller MR, Pedersen OF. Peak expiratory flow: conclusions and recommendations of a Working Party of the European Respiratory Society. Eur Respir J 1997 24 (Suppl.) : S2 8.
4. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics-2002. J Allergy Clin Immunol 2002 110 (Suppl.) : S141 219.
5. Global initiative for asthma. Global strategy for asthma management and prevention. Revised 2006.
6. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987 136 : 225 44.
7. Gern JE, Eggleston PA, Schuberth KC et al. Peak flow variation in childhood asthma: a three-year analysis. J Allergy Clin Immunol 1994 93 : 706 16.
8. Brand PL, Duiverman EJ, Postma DS, Waalkens HJ, Kerrebijn KF, van Essen-Zandvliet EE. Peak flow variation in childhood asthma: relationship to symptoms, atopy, airways obstruction and hyperresponsiveness. Eur Respir J 1997 10 : 1242 7.
9. Brand PL, Postma DS, Kerstjens HA, Koeter GH. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. Am Rev Respir Dis 1991 143 : 916 21.
10. Kerstjens HA, Brand PL, de Jong PM, Koeter GH, Postma DS. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. Thorax 1994 49 : 1109 15.
11. Oosterhoff Y, Koeter GH, De Monchy JG, Postma DS. Circadian variation in airway responsiveness to methacholine, propranolol, and AMP in atopic asthmatic subjects. Am Rev Respir Dis 1993 147 : 512 7.
12. Yoon KA, Lim HS, Koh YY, Kim H. Normal predicted values of pulmonary function tests in Korean school-aged children. J Korean Pediatr Assoc 1993 36 : 25 37.
13. Chai H, Farr RS, Froehlich LA et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975 56 : 323 7.
14. Joos GF, O'Connor B, Anderson SD et al. Indirect airway challenges. Eur Respir J 2003 21 : 1050 68.
15. American Thoracic Society. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000 161 : 309 29.
16. Avital A, Godfrey S, Springer C. Exercise, methacholine, and adenosine 5′-monophosphate challenges in children with asthma: relation to severity of the disease. Pediatr Pulmonol 2000 30 : 207 14.
17. Zar JH. Biostatistical Analysis, 3rd Edn. London : Prentice-Hall International, 1996.
18. Goldstein MF, Veza BA, Dunsky EH, Dvorin DJ, Belecanech GA, Haralabatos IC. Comparisons of peak diurnal expiratory flow variation, postbronchodilator FEV1 responses, and methacholine inhalation challenges in the evaluation of suspected asthma. Chest 2001 119 : 1001 10.
19. National Heart Lung and Blood Institute. International Consensus Report on Diagnosis and Treatment of Asthma. Eur Respir J 1992 5 : 601 41.
20. Higgins BG, Britton JR, Chinn S et al. The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis 1989 140 : 1368 72.
21. Reddel HK, Salome CM, Peat JK, Woolcock AJ. Which index of peak expiratory flow is most useful in the management of stable asthma? Am J Respir Crit Care Med 1995 151 : 1320 5.
22. Valletta EA, Comis A, Del Col G, Spezia E, Boner AL. Peak expiratory flow variation and bronchial hyperresponsiveness in asthmatic children during periods of antigen avoidance and reexposure. Allergy 1995 50 : 366 9.
23. Sly PD, Hibbert ME, Landau LI. Diurnal variation of peak expiratory flow rate in asthmatic children. Pediatr Pulmonol 1986 2 : 141 6.
24. Cote J, Cartier A, Malo JL, Rouleau M, Boulet LP. Compliance with peak expiratory flow monitoring in home management of asthma. Chest 1998 113 : 968 72.
25. Reddel H, Jenkins C, Woolcock A. Diurnal variability-time to change asthma guidelines? Brit Med J 1999 319 : 45 7.
26. Cockcroft DW, Davis BE, Todd DC, Smycniuk AJ. Methacholine challenge. Comparison of two methods. Chest 2005 127 : 839 44.
27. Prieto L, Reig I, Rojas R, Ferrer A, Domenech J. The effect of challenge method on sensitivity and reactivity to adenosine 5′-monophosphate in subjects with suspected asthma. Chest 2006 130 : 1448 53.
28. Josephs LK, Gregg I, Mullee MA, Holgate ST. Nonspecific bronchial reactivity and its relationship to the clinical expression of asthma. A longitudinal study. Am Rev Respir Dis 1989 140 : 350 7.
29. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax 1982 37 : 423 9.
30. van Velzen E, van den Bos JW, Benckhuijsen JA, van Essel T, de Bruijn R, Aalbers R. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996 51 : 582 4.
31. Sekerel BE, Saraclar Y, Kalayci O, Cetinkaya F, Tuncer A, Adalioglu G. Comparison of four different measures of bronchial responsiveness in asthmatic children. Allergy 1997 52 : 1106 9.
32. van Schoor J, Pauwels R, Joos G. Indirect bronchial hyper-responsiveness: the coming of age of a specific group of bronchial challenges. Clin Exp Allergy 2005 35 : 250 61.
33. ten Hacken NH, Timens W, Smith M, Drok G, Kraan J, Postma DS. Increased peak expiratory flow variation in asthma: severe persistent increase but not nocturnal worsening of airway inflammation. Eur Respir J 1998 12 : 546 50.